company was full of promise and hype for years but could never deliver on it.There last few ann went from a joint venture, we are buying them out, we give up we are broke.Good products, badly run
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025